National Research Corporation (NRC)
| Previous close | 41.50 |
| Open | 41.57 |
| Bid | 41.40 x 1000 |
| Ask | 41.53 x 800 |
| Day's range | 41.18 - 41.60 |
| 52-week range | 36.61 - 47.60 |
| Volume | |
| Avg. volume | 41,017 |
| Market cap | 1.018B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 35.75 |
| EPS (TTM) | 1.16 |
| Earnings date | 12 Feb 2024 - 16 Feb 2024 |
| Forward dividend & yield | 0.48 (1.16%) |
| Ex-dividend date | 28 Dec 2023 |
| 1y target est | N/A |
Simply Wall St.National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12
National Research Corporation's ( NASDAQ:NRC ) investors are due to receive a payment of $0.12 per share on 12th of...
GlobeNewswireNational Research Corporation Declares Quarterly Dividend
Lincoln, Nebraska, Nov. 17, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, January 12, 2024, to shareholders of record as of the close of business on Friday, December 29, 2023. For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique ind
Insider MonkeyNational Research Corporation (NASDAQ:NRC) Q3 2023 Earnings Call Transcript
National Research Corporation (NASDAQ:NRC) Q3 2023 Earnings Call Transcript November 8, 2023 Operator: Hello, everyone, and welcome to the National Research Corporation Third Quarter 2023 Earnings Call. My name is Charlie and I’ll be coordinating the call today. [Operator Instructions] I’ll now hand over to our host, Kevin Karas, Chief Financial Officer, to begin. Kevin, […]
